MiMedx Group Inc. Chief Executive Officer Parker “Pete” Petit will step down following external and internal investigations of the medical-product company’s sales tactics and government contracts.
The CEO will also give up his position as chairman of the board, though will stay on as a director. Chief Operating Officer and President William Taylor is also resigning, the company said in a statement Monday.
The resignations resulted “in part, from information the audit committee has identified through its previously announced independent investigation,” MiMedx said in the statement. “This investigation is ongoing and there may be other actions taken based, at least ...
Learn more about Bloomberg Law or Log In to keep reading:
See Breaking News in Context
Bloomberg Law provides trusted coverage of current events enhanced with legal analysis.
Already a subscriber?
Log in to keep reading or access research tools and resources.